CN102077940A - Special dietary marine food for patients with coronary heart disease - Google Patents
Special dietary marine food for patients with coronary heart disease Download PDFInfo
- Publication number
- CN102077940A CN102077940A CN2010102907759A CN201010290775A CN102077940A CN 102077940 A CN102077940 A CN 102077940A CN 2010102907759 A CN2010102907759 A CN 2010102907759A CN 201010290775 A CN201010290775 A CN 201010290775A CN 102077940 A CN102077940 A CN 102077940A
- Authority
- CN
- China
- Prior art keywords
- marine
- heart disease
- coronary heart
- patients
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000029078 coronary artery disease Diseases 0.000 title claims abstract description 52
- 235000013305 food Nutrition 0.000 title claims abstract description 26
- 235000005911 diet Nutrition 0.000 title abstract description 11
- 230000000378 dietary effect Effects 0.000 title abstract 6
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 48
- 239000005017 polysaccharide Substances 0.000 claims abstract description 48
- 235000012054 meals Nutrition 0.000 claims abstract description 43
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 40
- 239000011707 mineral Substances 0.000 claims abstract description 40
- 235000010755 mineral Nutrition 0.000 claims abstract description 40
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 39
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 39
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 29
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 29
- 229940088594 vitamin Drugs 0.000 claims abstract description 22
- 229930003231 vitamin Natural products 0.000 claims abstract description 22
- 235000013343 vitamin Nutrition 0.000 claims abstract description 22
- 239000011782 vitamin Substances 0.000 claims abstract description 22
- 235000015097 nutrients Nutrition 0.000 claims abstract description 21
- 150000001413 amino acids Chemical class 0.000 claims abstract description 19
- 239000002994 raw material Substances 0.000 claims abstract description 17
- 229920001542 oligosaccharide Polymers 0.000 claims abstract description 16
- 150000002482 oligosaccharides Chemical class 0.000 claims abstract description 10
- 239000000843 powder Substances 0.000 claims description 68
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 53
- 150000004804 polysaccharides Chemical class 0.000 claims description 45
- 235000000346 sugar Nutrition 0.000 claims description 41
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 28
- 150000001875 compounds Chemical class 0.000 claims description 28
- 235000018102 proteins Nutrition 0.000 claims description 28
- 235000016709 nutrition Nutrition 0.000 claims description 26
- 102000008186 Collagen Human genes 0.000 claims description 22
- 108010035532 Collagen Proteins 0.000 claims description 22
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims description 22
- 229920001436 collagen Polymers 0.000 claims description 22
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 22
- 235000010443 alginic acid Nutrition 0.000 claims description 21
- 229920000615 alginic acid Polymers 0.000 claims description 21
- 230000035764 nutrition Effects 0.000 claims description 20
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 20
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 19
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 18
- 239000000783 alginic acid Substances 0.000 claims description 18
- 229960001126 alginic acid Drugs 0.000 claims description 18
- 150000004781 alginic acids Chemical class 0.000 claims description 18
- 235000001014 amino acid Nutrition 0.000 claims description 17
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 16
- 239000011575 calcium Substances 0.000 claims description 16
- 229910052791 calcium Inorganic materials 0.000 claims description 16
- 241000251468 Actinopterygii Species 0.000 claims description 14
- 229910052742 iron Inorganic materials 0.000 claims description 14
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 13
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 13
- 210000000988 bone and bone Anatomy 0.000 claims description 13
- 239000011777 magnesium Substances 0.000 claims description 13
- 229910052749 magnesium Inorganic materials 0.000 claims description 13
- 239000011701 zinc Substances 0.000 claims description 13
- 229910052725 zinc Inorganic materials 0.000 claims description 13
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 12
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 12
- 229920001661 Chitosan Polymers 0.000 claims description 12
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 12
- 241000251730 Chondrichthyes Species 0.000 claims description 11
- 241000195474 Sargassum Species 0.000 claims description 11
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 11
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 11
- 239000013535 sea water Substances 0.000 claims description 11
- 229960003080 taurine Drugs 0.000 claims description 11
- FYGDTMLNYKFZSV-DZOUCCHMSA-N alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-DZOUCCHMSA-N 0.000 claims description 10
- 240000002900 Arthrospira platensis Species 0.000 claims description 9
- 235000016425 Arthrospira platensis Nutrition 0.000 claims description 9
- 241000512259 Ascophyllum nodosum Species 0.000 claims description 9
- 229920002101 Chitin Polymers 0.000 claims description 9
- 229920002567 Chondroitin Polymers 0.000 claims description 9
- 108010028690 Fish Proteins Proteins 0.000 claims description 9
- 241001465754 Metazoa Species 0.000 claims description 9
- 229910021529 ammonia Inorganic materials 0.000 claims description 9
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 claims description 9
- 229940082787 spirulina Drugs 0.000 claims description 9
- 241001324819 Dunaliella peircei Species 0.000 claims description 8
- 241000206575 Chondrus crispus Species 0.000 claims description 7
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 7
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 7
- -1 fructose oligosaccharides Chemical class 0.000 claims description 7
- 239000011591 potassium Substances 0.000 claims description 7
- 229910052700 potassium Inorganic materials 0.000 claims description 7
- 239000011669 selenium Substances 0.000 claims description 7
- 229910052711 selenium Inorganic materials 0.000 claims description 7
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 6
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 6
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 6
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 6
- 241001428166 Eucheuma Species 0.000 claims description 6
- 229930091371 Fructose Natural products 0.000 claims description 6
- 239000005715 Fructose Substances 0.000 claims description 6
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims description 6
- 229930064664 L-arginine Natural products 0.000 claims description 6
- 235000014852 L-arginine Nutrition 0.000 claims description 6
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims description 6
- 241000206607 Porphyra umbilicalis Species 0.000 claims description 6
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 6
- 229930003268 Vitamin C Natural products 0.000 claims description 6
- 229930003316 Vitamin D Natural products 0.000 claims description 6
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 6
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 6
- 229960001231 choline Drugs 0.000 claims description 6
- 229910052802 copper Inorganic materials 0.000 claims description 6
- 239000010949 copper Substances 0.000 claims description 6
- 239000000787 lecithin Substances 0.000 claims description 6
- 235000010445 lecithin Nutrition 0.000 claims description 6
- 229940067606 lecithin Drugs 0.000 claims description 6
- 229910052750 molybdenum Inorganic materials 0.000 claims description 6
- 239000011733 molybdenum Substances 0.000 claims description 6
- 235000001968 nicotinic acid Nutrition 0.000 claims description 6
- 229960003512 nicotinic acid Drugs 0.000 claims description 6
- 239000011664 nicotinic acid Substances 0.000 claims description 6
- 229940055726 pantothenic acid Drugs 0.000 claims description 6
- 235000019161 pantothenic acid Nutrition 0.000 claims description 6
- 239000011713 pantothenic acid Substances 0.000 claims description 6
- 235000010408 potassium alginate Nutrition 0.000 claims description 6
- 239000000737 potassium alginate Substances 0.000 claims description 6
- MZYRDLHIWXQJCQ-YZOKENDUSA-L potassium alginate Chemical compound [K+].[K+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O MZYRDLHIWXQJCQ-YZOKENDUSA-L 0.000 claims description 6
- 235000019155 vitamin A Nutrition 0.000 claims description 6
- 239000011719 vitamin A Substances 0.000 claims description 6
- 235000019154 vitamin C Nutrition 0.000 claims description 6
- 239000011718 vitamin C Substances 0.000 claims description 6
- 235000019166 vitamin D Nutrition 0.000 claims description 6
- 239000011710 vitamin D Substances 0.000 claims description 6
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 6
- 229940045997 vitamin a Drugs 0.000 claims description 6
- 229940046008 vitamin d Drugs 0.000 claims description 6
- 241000195649 Chlorella <Chlorellales> Species 0.000 claims description 5
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 5
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 5
- 229910052804 chromium Inorganic materials 0.000 claims description 5
- 239000011651 chromium Substances 0.000 claims description 5
- 235000005152 nicotinamide Nutrition 0.000 claims description 5
- 239000011570 nicotinamide Substances 0.000 claims description 5
- 229960003966 nicotinamide Drugs 0.000 claims description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 4
- 229920001817 Agar Polymers 0.000 claims description 4
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 4
- 241000212297 Pelvetia Species 0.000 claims description 4
- 241000196251 Ulva arasakii Species 0.000 claims description 4
- 239000008272 agar Substances 0.000 claims description 4
- 235000020247 cow milk Nutrition 0.000 claims description 4
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 4
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 3
- 235000010410 calcium alginate Nutrition 0.000 claims description 3
- 239000000648 calcium alginate Substances 0.000 claims description 3
- 229960002681 calcium alginate Drugs 0.000 claims description 3
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 claims description 3
- 235000010413 sodium alginate Nutrition 0.000 claims description 3
- 239000000661 sodium alginate Substances 0.000 claims description 3
- 229940005550 sodium alginate Drugs 0.000 claims description 3
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 2
- 229930003427 Vitamin E Natural products 0.000 claims description 2
- 229960000304 folic acid Drugs 0.000 claims description 2
- 235000019152 folic acid Nutrition 0.000 claims description 2
- 239000011724 folic acid Substances 0.000 claims description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 2
- 235000019165 vitamin E Nutrition 0.000 claims description 2
- 229940046009 vitamin E Drugs 0.000 claims description 2
- 239000011709 vitamin E Substances 0.000 claims description 2
- 230000036039 immunity Effects 0.000 abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 8
- 208000024891 symptom Diseases 0.000 abstract description 6
- 239000000463 material Substances 0.000 abstract description 5
- 230000009286 beneficial effect Effects 0.000 abstract description 4
- 230000000975 bioactive effect Effects 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 4
- 239000013589 supplement Substances 0.000 abstract description 3
- 238000002156 mixing Methods 0.000 abstract description 2
- 150000004676 glycans Chemical class 0.000 abstract 2
- 238000009835 boiling Methods 0.000 abstract 1
- 235000003715 nutritional status Nutrition 0.000 abstract 1
- 230000006870 function Effects 0.000 description 22
- 230000000694 effects Effects 0.000 description 21
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 20
- 239000000047 product Substances 0.000 description 20
- 210000004369 blood Anatomy 0.000 description 18
- 239000008280 blood Substances 0.000 description 18
- 235000019688 fish Nutrition 0.000 description 13
- 238000005516 engineering process Methods 0.000 description 10
- 230000002265 prevention Effects 0.000 description 9
- 235000012000 cholesterol Nutrition 0.000 description 8
- 230000001603 reducing effect Effects 0.000 description 8
- 210000000936 intestine Anatomy 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 230000036541 health Effects 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- 230000033228 biological regulation Effects 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 235000013312 flour Nutrition 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 150000002484 inorganic compounds Chemical class 0.000 description 5
- 229910010272 inorganic material Inorganic materials 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 235000013372 meat Nutrition 0.000 description 5
- 150000002894 organic compounds Chemical class 0.000 description 5
- 230000032683 aging Effects 0.000 description 4
- 210000001188 articular cartilage Anatomy 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 229940063755 folic acid 0.1 mg Drugs 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 230000001077 hypotensive effect Effects 0.000 description 4
- 230000035790 physiological processes and functions Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 229940104933 vitamin E 3 mg Drugs 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 3
- 208000001953 Hypotension Diseases 0.000 description 3
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 230000010100 anticoagulation Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 210000004087 cornea Anatomy 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 230000002218 hypoglycaemic effect Effects 0.000 description 3
- 208000021822 hypotensive Diseases 0.000 description 3
- 238000005213 imbibition Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 229910052748 manganese Inorganic materials 0.000 description 3
- 239000011572 manganese Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 208000031225 myocardial ischemia Diseases 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000012659 Joint disease Diseases 0.000 description 2
- 241001417045 Lophius litulon Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 241000237509 Patinopecten sp. Species 0.000 description 2
- 206010040925 Skin striae Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 229940072056 alginate Drugs 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 235000009697 arginine Nutrition 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 235000004251 balanced diet Nutrition 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 210000000748 cardiovascular system Anatomy 0.000 description 2
- 239000003653 coastal water Substances 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 210000001508 eye Anatomy 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 229960002591 hydroxyproline Drugs 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000004347 intestinal mucosa Anatomy 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 235000020637 scallop Nutrition 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 235000015170 shellfish Nutrition 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 2
- 235000020985 whole grains Nutrition 0.000 description 2
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 1
- UBLAMKHIFZBBSS-UHFFFAOYSA-N 3-Methylbutyl pentanoate Chemical compound CCCCC(=O)OCCC(C)C UBLAMKHIFZBBSS-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000881711 Acipenser sturio Species 0.000 description 1
- 102000005606 Activins Human genes 0.000 description 1
- 108010059616 Activins Proteins 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000965254 Apostichopus japonicus Species 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000258957 Asteroidea Species 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- AEMOLEFTQBMNLQ-BZINKQHNSA-N D-Guluronic Acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@@H](O)[C@H]1O AEMOLEFTQBMNLQ-BZINKQHNSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-VANFPWTGSA-N D-mannopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-VANFPWTGSA-N 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010013774 Dry eye Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000021663 Female sexual arousal disease Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 241000276438 Gadus morhua Species 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 241000251511 Holothuroidea Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010049976 Impatience Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 241001596950 Larimichthys crocea Species 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 206010051131 Mastoptosis Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241000237852 Mollusca Species 0.000 description 1
- 241000237536 Mytilus edulis Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 241000263300 Paphia undulata Species 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000490567 Pinctada Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 208000006262 Psychological Sexual Dysfunctions Diseases 0.000 description 1
- 241000879903 Pteria Species 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- 241000238371 Sepiidae Species 0.000 description 1
- 108010054866 Shellfish Proteins Proteins 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- 241001125843 Trichiuridae Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000000488 activin Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- AEMOLEFTQBMNLQ-UHFFFAOYSA-N beta-D-galactopyranuronic acid Natural products OC1OC(C(O)=O)C(O)C(O)C1O AEMOLEFTQBMNLQ-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-QZABAPFNSA-N beta-D-glucosamine Chemical compound N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-QZABAPFNSA-N 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 210000000695 crystalline len Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000019007 dietary guidelines Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000004833 fish glue Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000005184 men's health Effects 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000020638 mussel Nutrition 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000007180 physiological regulation Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 201000010041 presbyopia Diseases 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000979 retarding effect Effects 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 210000003786 sclera Anatomy 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 230000009233 sperm competition Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 230000010148 water-pollination Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a special dietary marine food for patients with coronary heart disease. The special dietary food is prepared from food-borne marine oligopeptides as a main raw material by adding marine bioactive polysaccharides and mixing with seawood meal, nutrient amino acids, oligosaccharides, nutrients, vitamins and mineral substances as auxiliary materials. The special dietary marine food provided by the invention can be made into a powdery or granular food and is eaten after being dissolved in warm boiling water. The special dietary marine food provided by the invention is easy to dissolve, has greatest biological absorbability and greatest bioavailability on human bodies, provides high-quality marine proteins, active factors and nutrient components for organism, supplements various vitamins and mineral substances necessary for human bodies, and is beneficial to improving the nutritional status of the patients with coronary heart disease. Through the combined action of multiple factors comprising the bioactive components, the seawood meal, the nutrient amino acids and the like in the food-borne marine oligopeptides and the marine bioactive polysaccharides, the symptoms of the patients with coronary heart disease can be improved, the immunity of organisms can be increased, and the occurrence of complications of coronary heart disease can be prevented. The special dietary marine food is applicable for patients with coronary heart disease.
Description
Technical field
The present invention relates to a kind of special meals product, especially relate to and a kind ofly can replenish the needed by human nutrient, improve the body nutrition condition, and utilize the function factor in the marine active polysaccharide to regulate body function, be fit to the special meals product in the edible ocean of patients with coronary heart disease.
Background technology
Coronary heart disease is because the serious atherosis or spasm of coronary artery causes luminal stenosis, obturation to cause a kind of heart disease of myocardial ischemia-anoxemia or infraction, also claims ischemic heart disease.Coronary heart disease is the common type that atherosclerotic causes organ lesion, also is the healthy common diseases of harm the elderly.Raising along with living standards of the people, coronary heart disease is the trend that rises year by year in the illness rate of China at present, and sicken age is tending towards rejuvenation, it is threatening human health with high M ﹠ M, therefore, can 21 century, China faces the challenge of angiocardiopathy, control " first killer " of harm humans health, and key is prevention.
Have result of study to show: the diet of high heat, higher fatty acid, high cholesterol, high sugar, Incidence of CHD is improved greatly, become the high main cause of Incidence of CHD.Marine oligopeptide is the good protein source, absorbs and the utilization rate height, promptly can replenish protein; can avoid Excessive Intake heat and fat again; be beneficial to the drainage that promotes cholesterol and reduce blood cholesterol levels, thereby the protection cardiovascular system is the ideal complement product of patients with coronary heart disease balanced diet.Nutritional need according to patients with coronary heart disease, with the marine oligopeptide is the special meals product of patients with coronary heart disease of primary raw material preparation, not only replenish an amount of high-quality protein, and marine active polysaccharide and multiple function factor have been added, can obviously strengthen resistance against diseases, more can have the complication that alleviates coronary heart disease symptom and prevention coronary heart disease to take place.
Abroad, there are clear and definite regulation and perfect standard criterion in American-European developed country to food for special foods, and generally accepts for people.China has worked out " Chinese residents dietary guidelines " at present, and this guide was revised in 2007, is main regulatory documents with " packing food for special foods label general rule GB 13432-2004 in advance ".In this general rule, special diet is defined as: " be the physiological requirements of satisfying some special population, or some disease patient's nutritional need, press the food of the special processing of special formulation ".The science essence of special population diet regulation and control is: the control regular diet, replenish special diet, and strengthen at nutrition, reduce the metabolism burden, promote healthy.
Marine organisms are in the so special enclosed environment of seawater for a long time, metabolic system different and body defending system have been produced during evolution with terrestrial life, therefore it is special to contain many functions in the marine organisms, the physiological activator that structure is special, specificity based on marine protein resource growing environment, there is function in its polypeptide chain, the active fragment of novel structure, select suitable these polypeptide chains of protease hydrolytic, the fragments of peptides of biologically active is discharged, thereby can prepare marine oligopeptide with various physiological functions, they are that 2-6 amino acid is formed, molecular weight ranges is in the little molecular mixing peptide class of 200-1000Dalton, can directly be absorbed, human body is had maximum bio-absorbable degree and maximum bioavilability by body intestines wall mucomembranous cell.
Marine organisms existence is in high salt, high pressure, anoxic, unglazed special ecological environment, the polysaccharide of its generation will born important physiological function, it is the important active material of a class, proved to have various physiological regulation functions from the isolated polysaccharide of various marine organisms, some is for improving the comprehensive physique of body, improving coronary heart disease symptom and have important function.Utilize marine bioactivity polysaccharide scientifically and rationally, have positive effect improving body condition.
At present, what be useful on the China market that protein replenishes contains peptide food, but in patent documentation and non-patent literature, all do not find with food source property marine oligopeptide and marine bioactivity polysaccharide be that primary raw material is made, specially for the record of the edible special meals product of patients with coronary heart disease.
Summary of the invention
The deficiency that the objective of the invention is physilogical characteristics, nutritional need and conventional meals thereof at patients with coronary heart disease, a kind of special meals product in ocean of coronary heart disease special use are provided, this food has the body of improvement nutrition condition, realizes the help body, improves coronary heart disease symptom, conditioning body function of intestinal canal waits until effect.
For reaching above-mentioned purpose, the special meals product in the ocean of a kind of patients with coronary heart disease special use provided by the invention, with food source property marine oligopeptide is primary raw material, adds marine bioactivity polysaccharide, is aided with seawood meal, nutrition amino acid, compound sugar, nutrient, vitamin and mineral matter again and is mixed with and forms.
The weight portion proportioning of the raw material of the special meals product in the ocean of patients with coronary heart disease special use provided by the invention is:
Marine oligopeptide 3.5-5.0
Marine bioactivity polysaccharide 1.0-2.0
Seawood meal 1.2-1.8
Nutrition amino acid/11 .0-1.5
Compound sugar 1.0-1.5
Nutrient 0.1-0.5
Vitamin 0.01-0.1
Mineral matter 0.1-0.5.
The special meals product in ocean of the present invention can be made powdery or granule state food, with edible after the warm dissolved in boiled water.
The primary raw material of the special meals product in ocean of the present invention is:
Marine oligopeptide:
Marine oligopeptide of the present invention is meant the small molecule protein that utilizes hydrolysis or bio-enzyme engineering technology separation and Extraction from food source property marine animal or Sargassum protein.Its mean molecule quantity is below 1000Dalton, and is soluble in water, to acid, thermally-stabilised, can not need directly absorbs through digestion, has good bio-absorbable degree and bioavilability.
Except that trophic function, marine oligopeptide also has a series of physiological active functions:
1, auxiliary adjustment blood sugar: have the human clinical trial to show, marine oligopeptide can significantly reduce diabetes B patient's fasting blood glucose level, blood sugar there is the stable regulation effect, can improve diabetes B patient's sugar tolerance, and can significantly improve the sensitiveness of patient, and improve patient's insulin secretion function to insulin.
2, aided blood pressure-lowering: the collagen deficiency can cause the blood vessel elasticity variation, and influences blood pressure stabilization, even causes various cardiovascular and cerebrovascular diseases.Replenish marine oligopeptide, can accelerate vascular wall metabolism, increase blood vessel elasticity, strengthen the capilary strength and toughness, reduce triglyceride and cholesterol in the blood, make the blood smoothness, effectively aided blood pressure-lowering.
3, fat-reducing: contain abundant hydroxyproline in the marine oligopeptide, be a kind of have multiple important physiological function and unique bioactive amino acid, the principle of hydroxyproline reducing weight and blood fat is the activity that it can start lipase, make this lipolytic metabolic process increase and prolong, thereby the more fat of burning reach the purpose of fat-reducing.
4, protection heart: marine oligopeptide is the high-quality protein of marine animal and plant; human body there is good affinity; be easy to be drawn by human body and utilize; and be rich in unrighted acid; help promoting the drainage of cholesterol and reduce blood cholesterol levels; thereby the protection cardiovascular system is the ideal complement product of patients with coronary heart disease balanced diet.
5, protecting and nourishing liver: collagen peptide can directly be absorbed by human body fully, alleviated the work load of liver, simultaneously liver cell had excellent repairing, nourishing effect, can promote hepatocellular recovery and new life, strengthen the detoxification ability of liver, optimize the liver environment, to reach the effect of protecting and nourishing liver.
6, recover people's physique post-abortion: the women in the stream of people, postpartum, major part has mastoptosis, lax, the breast color is dark, and characteristics appear in striae of pregnancy, and replenishing collagen can suppress the pigment generation in advance, reducing color spot forms, repair skin, the desalination striae of pregnancy increases skin elasticity, promotes skin fineness; Simultaneously, promote the breast connective tissue to generate, guarantee the tall and straight fitness of breast.
7, safeguard the bone joint: marine oligopeptide is repairing articular cartilage effectively, recovers the lubricated of articular cartilage surface, reduces friction, and prevents calcium loss, reaches the effect of prevention of osteoporosis, and it is aging to delay bone.The ossein peptide can be strengthened the lubricity of articular cartilage when motion, and arthralgia is alleviated in the protection joint, reduces arthritic incidence, avoids delaying the generation of Degenerated Joint Disease.
8, improve Menopause: climacteric metancholia is that the hormone in vivo secretory volume reduces or stops to secrete and causes a series of illnesss of endocrinopathy.Clinical manifestation is comparatively complicated, occur feeling dizzy, dysbolism, insomnia, impatience, have no peace of mind, a series of physiology, pathological changes such as frigidity, behavior change.Marine oligopeptide is balanced in nutrition, supplementing qi and nourishing yin is arranged, protect ovary, regulates endocrine, delays the effects such as atrophy of sexual gland, can effectively prevent and alleviate the climacteric obstacle.
9, skin care body beautification: collagen accounts for 72% in the skin, and 80% is collagen in the corium, and collagen has constituted a fine and closely woven elasticated net in the skin peptide, pins moisture, is supporting the skin peptide.The loss of collagen, cause supporting the elasticated net fracture of skin, the skin histology atrophy, subside, skin will manifest aging phenomenons such as drying, coarse, lax, wrinkle, pore are thick, dim, color spot, additional marine oligopeptide can make skin peptide elasticity recovery, pliable and tough full, collagen peptide can be removed interior free yl in addition, and multipath is anti-oxidant, slows down skin senescence.
10, improve memory: collagen runs off and causes failure of memory with advancing age, absent minded, contain a large amount of amino acid in the collagen, not only participate in synthetic new collagen, but also be a kind of nervous centralis inhibition mechanism in the brain cell, replenish marine oligopeptide, can regulate internal system, add excitometabolic, suppress the brain excitement process, alleviate brain fatigue, obviously improve memory.
11, improve eyesight: the main component of cornea is a collagen, and collagen runs off and causes eyes dry and astringent with advancing age, fatigue.The cornea transparency is not good, elastomer hardening, crystalline lens muddiness, eye illnesses such as the cataract that causes.Additional marine oligopeptide can make the eyes printing opacity, and it is transparent that cornea keeps, and keeps the elasticity of crystalline, improves phenomenons such as presbyopia and eye fatigue.In addition, marine oligopeptide also helps sclera health, tough and tensile.
12, improve the prostate syndrome: scientific research proves, contains abundant arginine in the marine oligopeptide, is that the sexual life of men's health is essential, and arginic content is determining the power of spermatozoon activity, sperm competition power in the seminal fluid.Marine oligopeptide also can supply cavernous body required colloid, and is bearing and supplying with the effect that stimulates the glandular secretion that can produce hormone, helps to improve prostatic health status.
13, improve body immunity: marine oligopeptide has anti-oxidant and radiation-resisting functional, and can, fast Absorption direct by human body.Marine oligopeptide can organically combine with immunocyte, the human activin immunity function, and immunity functions such as macrophage, lymph corpuscle, plasma cell and immunoglobulin (Ig) will improve, thereby obviously improve body immunity.
14, promote mineral matter to absorb: marine oligopeptide improves the transhipment ratio of mineral matter by the chelating with mineral matter such as calcium, iron, zinc etc. in enteron aisle, increases the absorptivity of mineral matter.
Marine oligopeptide of the present invention is a kind of, several or whole in marine fish protein peptides, seashells protein peptides, Sargassum protein peptide, marine fish collagen peptide and the sea bone peptide.
Marine fish protein peptides of the present invention is meant that with coastal waters and off-lying sea fish (as large yellow croaker, hairtail, tuna etc.), deep-sea fish (as salmon, cod etc.) be raw material, utilize the biological hydrolysis technology, the liquid fish matter of extracting, its mean molecule quantity is lower than 1000Dalton.
Seashells protein peptides of the present invention is meant that with oyster meat, scallop, pearl oyster meat, mussel meat, clam meat, paphia undulata meat be raw material, utilizes biological enzymolysis technology, the enzymolysis shellfish protein of extraction, and its mean molecule quantity is lower than 1000Dalton.
Marine fish collagen peptide of the present invention is meant that the fish glue from skin with coastal waters and off-lying sea fish (as horse glue fish etc.), deep-sea fish (as anglerfish etc.) is a raw material, utilize biological enzymolysis technology, the enzymolysis collagen matter of extracting, its mean molecule quantity is lower than 1000Dalton.
Sea bone peptide of the present invention is meant that the fish-bone with marine fish (as cobio, squid, cod, sturgeon, shark, anglerfish) is a raw material, utilizes biological enzymolysis technology, the small protein of extraction, and its mean molecule quantity is lower than 1000Dalton.
Sargassum protein peptide of the present invention is meant that with marine alga (as seawater spirulina, chlorella etc.) be raw material, utilizes biological enzymolysis technology, the Sargassum protein peptide that extracts.
Marine bioactivity polysaccharide:
Marine bioactivity polysaccharide of the present invention is an algal polysaccharides, a kind of in ocean shell class polysaccharide and the marine animal polysaccharide, several or whole, wherein said algal polysaccharides is an agar, sodium alginate, carragheen, fucoidin, potassium alginate, calcium alginate, alginic acid zinc, a kind of in alginic acid iron and the alginic acid magnesium, several or whole, described ocean shell class polysaccharide is a pearl powder, nacreous layer powder, chitosan, a kind of in chitin oligo saccharide and the ammonia sugar, several or whole, described marine animal polysaccharide is one or both in glycosaminoglycan and the shark chondroitin.
Algal polysaccharides:
1) alginate is present in a kind of natural polysaecharides material in the brown algas such as sea-tangle, bulk kelp, is the natural products that alginic acid in the frond and the mineral matter in the seawater generate, the mixed polysaccharide that gathers that alginic acid is made up of mannuronic acid (M) and guluronic acid (G).Algal polysaccharides is a kind of edible and don't by the macromolecular polysaccharide of human consumption, it has effects such as water imbibition, adsorptivity, cationic exchange and gel filtration in stomach and intestine, have following function: hypoglycemic, hypotensive, reducing blood lipid, reduce cholesterol, the prevention fatty liver; Hinder the absorption of radioactive element, help to get rid of heavy metal of body; Increase satiety, health slimming; Accelerate enterogastric peristalsis, the prevention constipation.Have stronger biologically active through degraded alginate, have following obvious health care effect: low molecule potassium alginate can be regulated and prevent hypertension, retarding cardiovascular aging, improve microcirculation; But low molecule sodium alginate reducing blood lipid; Low molecule calcium alginate is the novel calcium source of supplementary calcium food, is easy to absorb; But low molecule alginic acid zinc brain tonic and intelligence development and prevention person in middle and old age dementia; Low molecule alginic acid iron can be mended iron, enrich blood; Low molecule alginic acid magnesium can prevent and treat coronary heart disease.
2) fucoidin: fucoidin claims fucoidin, algal polysaccharide sulfate again, it is peculiar marine active polysaccharide in the brown algae sea-plant (sea-tangle etc.), belong to rare sulfuric ester ionic natural polysaccharide at occurring in nature, show with clinical research through a large amount of experiments, product have the immunity of raising, hypoglycemic, anticoagulation, reducing blood lipid, hypotensive, suppress renal failure, physiologically active such as antitumor.
3) carragheen: extract with red algaes such as Irish moss, by 1,3-β-D-galactopyranose and 1, the straight-chain polysaccharide sulfuric ester of 4-β-alternate be combined into of D-galactopyranose has anticoagulation and effect for reducing blood fat.Carragheen has the fundamental characteristics of soluble dietary fiber, and the carragheen after the degradation in vivo can form the complex compound of solubility with fibrin.Can be become CO by big enterobacteria glycolysis
2, H
2, SCFA such as biogas and formic acid, acetate, propionic acid, become the energy source of probio.The carragheen imbibition also forms high viscosity and is stained with liquid, and the sense of tangible born of the same parents' abdomen is arranged under one's belt, can be used for fat-reducing.
Ocean shell class polysaccharide:
1) pearl powder
Pearl powder contains 18 seed amino acids, and wherein 7 kinds is the calcium carbonate of essential amino acid, aragonite structure, 20 various trace elements and Cobastab.The Pharmacopoeia of the People's Republic of China and " Chinese medicine voluminous dictionary " all indicate: pearl has effects such as the arresting convulsion of calming the nerves, the screen that makes eye bright, detoxify and promote granulation, and modern study shows that also pearl powder is in the effect that improves body immunity, delays senility, aspects such as freckle removing and whitening, supplement calcium all have uniqueness.Strengthen that immunity, supplement calcium, Bao Chunyan decline, improvement is slept, treat ulcer, nourish the liver to improve visual acuity, secondary buck.
2) chitosan, chitin oligo saccharide
Chitosan has the reinforced immunological function, to cancer inhibitory action arranged, suppress aging, reduce cholesterol, hypotensive activity, reinforcement liver function, to the regulating action of neural, internal system, improve have a pain in the back, harmful substance and be excluded in external in the adsorbent.
Chitosan is obtained chitin oligo saccharide through special biological enzyme technology processing, be water-soluble better, function is big, biologically active is high low molecular weight product, studies have shown that: chitin oligo saccharide has the immunity of raising, suppress the growth of cancerous swelling cell, promote liver spleen antibody to form, promote the absorption of calcium and mineral matter, human body beneficial's floras such as propagation Bifidobacterium, lactic acid bacteria, reducing blood lipid, hypotensive, hypoglycemic, adjusting cholesterol, fat-reducing, functions such as prevention AD.
3) ammonia sugar
The full name of ammonia sugar is the D-Glucosamine, can be divided into D-aminoglucose hydrochloride and D-aminoglucose sulfate.Ammonia sugar is the important component part of the extremely strong proteoglycan of hydrophily, and the collagen in its energy synthesized human very easily is absorbed by the body.Ammonia sugar is widely used as the nutritious supplementary pharmaceutical of articular cartilage, be the unique approval of American-European medical circle bone and joint diseases is had the nutrient and healthcare products of therapeutic action.
The marine animal polysaccharide:
1) glycosaminoglycan:
Isolate various glycosaminoglycans after extracting from marine animals such as stichopus japonicus, sea cucumber, starfish, shark, cuttlefish, scallop, crustacean pteria martensii, it has various active such as anticoagulation, antitumor, reducing blood lipid, raising immunity.
2) shark chondroitin:
Shark chondroitin has diseases such as beautifying face and moistering lotion, strong muscles and bones, antirheumatic arthritis, pre-anti-cancer and tumour, coronary heart disease, angina pectoris, myocardial infarction, coronary atherosclerosis, myocardial ischemia, no obvious toxic and side effects can significantly reduce the M ﹠ M of patients with coronary heart disease.
Algal polysaccharides of the present invention is meant that extracting alginic acid from marine alga combines with various mineral matter elements, and drying is pulverized the flour that is prepared from again.
Ocean of the present invention shell class polysaccharide is meant the flour that pearl or mother pearl shellfish are prepared from by physical method; Chitosan, chitin oligo saccharide and ammonia sugar are that chitin is passed through biochemical technology or biological enzymolysis technology, and drying is pulverized the flour that is prepared from again.
Marine animal polysaccharide of the present invention is meant sea mollusk, shellfish, fish-bone through enzymolysis, filtering albumen and purifying, concentrates or spray-drying and the flour for preparing through vacuum again.
Seawood meal:
Food source property marine algae is rich in trace elements such as algin, sweet mellow wine, vitamin and multi mineral prime element such as potassium, iron, calcium, phosphorus, iodine, selenium, cobalt, also contains crude protein 10%-40%, crude fat 0.30%-50%, carbohydrate 30%-60%.Scientific research shows, seawood meal can be regulated the metabolic function of human body, strengthens immunity, health care, benefit brain and enhancing intelligence, anti-ageing, can prevent thyroid gland enlargement, ephrosis, strengthening skin gloss and elasticity, softening blood vessel, reduction cholesterol, is a kind of cosmetic good merchantable brand; All right lipopenicillinase, step-down prevent obesity, hypertension, cardiovascular disease etc.
Seawood meal of the present invention is a kind of, several or whole in seawater spirulina powder, chlorella powder, Dunaliella peircei powder, ulva lactuca powder, sea-tangle powder, skirt dish powder, laver powder, kelp powder, Algemin, pelvetia silquosa powder and the Eucheuma powder.
Seawood meal of the present invention is meant marine alga is cleaned, removes raw meat, filters and mix, dry, pulverize and the flour of preparation.
Nutrition amino acid:
Amino acid is to constitute organism protein and with vital movement the most basic relevant material, is the base unit that constitutes protein molecule in vivo, with the vital movement of biology confidential relation arranged.It has special physiological function in antibody, be one of indispensable nutritional labeling in the organism, confirms that through medical research L-arginine, taurine, L-citrulling, L-aminobutanedioic acid have the function of auxiliary hyperglycemic.
Nutrition amino acid of the present invention is a kind of, several or whole in L-arginine, taurine, L-citrulling and the L-aminobutanedioic acid.
Compound sugar:
Compound sugar claims oligosaccharides again.Functional oligose is not absorbed by human consumption, is not utilized by most enteron aisle spoilage organisms yet, thereby can suppress the spoilage organisms growth, helps to improve and keep the enteron aisle normal function.Long-term edible can delay senility, defaecation, lose weight, keep blood sugar level, improve the nutrient absorption rate, particularly can improve the absorption of body calcium, iron, zinc ion.As flavor enhancement, avoided the drawback of sweeteners such as sucrose with compound sugar with a lot of BAs.
Compound sugar of the present invention is a kind of, several or whole in malto-oligosaccharide, galactolipin compound sugar, fructose oligosaccharides, oligoisomaltose, cow's milk compound sugar and the xylo-oligosaccharide.
Nutrient:
Nutrient is the essential material of human body cell produce power.It extensively is present in the organism, in human body, mainly concentrates the more position of consumed energy, is generally supported as the nutrition of prevention coronary heart disease at present.
Nutrient of the present invention is a kind of, several or whole among lecithin, D-ribose and the co-ferment Q10.
Vitamin and mineral matter:
Vitamin and mineral matter are the nutrients of needed by human.
Vitamin of the present invention is vitamin A, vitamin D, vitamin E, vitamin C, Cobastab
1, Cobastab
2, Cobastab
6, Cobastab
12, a kind of, several or whole in nicotinic acid, folic acid, pantothenic acid, choline and the niacinamide.
Mineral matter described in the present invention is a kind of, several or whole in calcium, potassium, magnesium, iron, zinc, selenium, manganese, copper, chromium and the molybdenum.
The interpolation form of mineral matter of the present invention is the organic or inorganic compound of this mineral matter.
The addition of vitamin and minerals (6B14880-1994) is carried out with " vitamin, mineral types and consumption " of " regulation (trying) is declared and evaluated to nutrient prime replenisher " middle regulation that on July 1st, 2005, State Food and Drug Administration formally came into effect with reference to " DRIs ", " the food enrichment use sanitary standard " of Chinese Soclety of Nutrition's promulgation in 2000 among the present invention.
Above-mentioned various raw material mixes, and can keep its powdery, or through granulation, makes powdery or granule state food.
The special meals product in the ocean of patients with coronary heart disease special use provided by the invention, achievement in research with reference to marine biology and marine life science, the achievement in research of modern nutriology and the traditional methods to keep in good health theory that keeps healthy is combined its characteristic and the effect of body mainly shown the following aspects:
1, improves coronary heart disease
The present invention will have the protection cardiac function various batchings carry out the science compatibility, various functions are merged, and, improve the effect of improving coronary heart disease symptom and protection heart by the synergy between the active ingredient.
2, balanced in nutrition
Effectively replenish the patients with coronary heart disease desired nutritional, improve nutrition condition, strengthen patient's resistance, help keeping the enteron aisle normal function, simultaneously,, by the synergy of marine oligopeptide and marine bioactivity polysaccharide and multiple function factor, help improving coronary heart disease symptom, prevention coronary heart disease complication.
3, be easy to absorb
Utilize prescription of the present invention, various components adopt the food of suitable ratio collocation preparation, ooze state through being after a certain amount of water-soluble separating to wait, and can arrive small intestine by stomach fast, absorb soon, can replenish the patients with coronary heart disease desired nutritional rapidly.Marine oligopeptide has more increased the absorptivity of mineral matter element by after closing with the huge legendary turtle of calcium, iron, zinc etc.
4, strengthen immunity
Marine active polysaccharide in the present invention's prescription, have physiological activator wherein effect, the marine oligopeptide of building up resistance can improve immunity of organisms, compound sugar also can strengthen the many aspects such as synergy of immunity of organisms, marine oligopeptide and marine active polysaccharose substance by the growth and breeding that promotes beneficial bacteria of intestinal tract factor, can obviously strengthen the resistivity of body, the generation of complication such as minimizing infection.
5, improve functions of intestines and stomach
Algal polysaccharides and seawood meal are rich in the ocean dietary fiber, has the very strong outlet capacity of tiing up, imbibition is original 50-200 times in intestines, form the very high colloidal solution of viscosity, with the large intestine contents mixed, increase the moisture of ight soil, because the moisture in the colloidal solution is difficult for being played the effect that ight soil is preserved moisture by big intestinal absorption.In addition, colloidal solution sticks on the large intestine inwall, plays the effect of lubricious enteron aisle, helps the discharge of ight soil.Compound sugar suppresses the growth of spoilage organisms by promoting the growth and breeding of probio in the intestines, forms on the intestinal mucosa surface simultaneously and protects barrier together, can resist the damage of enteron aisle spoilage organisms to intestinal mucosa, reduces the absorption of intestinal toxic material.Compound sugar can promote intestines peristalsis, quickens the discharge of residuals in the intestines, helps preventing constipation.
The specific embodiment
Following examples only are used to set forth the present invention, and protection scope of the present invention is not only to be confined to following examples.The those of ordinary skill of described technical field all can be realized purpose of the present invention according to above content disclosed by the invention and scope that each parameter is got.
Embodiment 1
The special meals product (powdery) in ocean of preparation patients with coronary heart disease special use
Present embodiment is selected powdery marine fish protein peptides, seashells protein peptides, Sargassum protein peptide, marine fish collagen peptide, sea bone peptide, potassium alginate, alginic acid magnesium, agar, chitosan, shark chondroitin, seawater spirulina powder, kelp powder, Dunaliella peircei powder, skirt dish powder, Eucheuma powder, taurine, L-arginine, L-citrulling, D-ribose, L-aminobutanedioic acid, malto-oligosaccharide, lecithin, D-ribose, co-ferment Q10 and various vitamin and mineral matter, presses column weight amount proportioning and is prepared:
(1) marine oligopeptide: marine fish protein peptides 1.5g, seashells protein peptides 1.0g, Sargassum protein peptide 0.5g, marine fish collagen peptide 0.5g, sea bone peptide 0.5g;
(2) marine bioactivity polysaccharide: potassium alginate 0.5g, alginic acid magnesium 0.3g, chitosan 0.3g, shark chondroitin 0.2g, agar 0.2g;
(3) seawood meal: seawater spirulina powder 0.3g, kelp powder 0.3g, Dunaliella peircei powder 0.3g, skirt dish powder 0.3g, Eucheuma powder 0.3g;
(4) nutrition amino acid: taurine 0.5g, L-arginine 0.4g, L-citrulling 0.3g, L-aminobutanedioic acid 0.3g;
(5) compound sugar: malto-oligosaccharide 1.2g;
(6) nutrient: lecithin 0.2g, D-ribose 0.05g, co-ferment Q10 0.05g;
(7) vitamin: vitamin A 0.2mg, vitamin E 3mg, vitamin C 30mg, vitamin D 0.1mg, Cobastab
10.5mg, Cobastab
20.5mg, Cobastab
60.5mg, Cobastab
120.1mg, nicotinic acid 0.5mg, folic acid 0.1mg, pantothenic acid 1mg, choline 50mg, niacinamide 0.5mg;
(8) mineral matter (the interpolation form of mineral matter is the organic or inorganic compound of this mineral matter): calcium 200mg, potassium 100mg, magnesium 100mg, iron 5mg, zinc 5mg, selenium 0.01mg, manganese 1mg, chromium 0.01mg, copper 0.1mg, molybdenum 0.01mg.
Above-mentioned raw materials is mixed, stir,, make powdered food through super-dry.After about 150ml temperature dissolved in boiled water, directly drink or take in through nasal feeding.
Embodiment 2
The special meals product (graininess) in ocean of preparation patients with coronary heart disease special use
Present embodiment is selected marine fish protein peptides, Sargassum protein peptide, sea bone peptide, potassium alginate, alginic acid magnesium, chitosan, seawater spirulina, kelp powder, Dunaliella peircei powder, taurine, arginine, malto-oligosaccharide, D-ribose, co-ferment Q10 and the various vitamin and the mineral matter of powdery, presses column weight amount proportioning and is prepared:
(1) marine oligopeptide: marine fish protein peptides 2.0g, Sargassum protein peptide 1.0g, sea bone peptide 1.0g;
(2) marine bioactivity polysaccharide: alginic acid magnesium 1.0g, shark chondroitin 0.3g, chitosan 0.2g;
(3) seawood meal: Dunaliella peircei powder 0.5g, seawater spirulina powder 0.5g, kelp powder 0.5g;
(4) nutrition amino acid: taurine 0.5g, L-arginine 0.5g;
(5) compound sugar: malto-oligosaccharide 1.4g;
(6) nutrient: co-ferment Q10 0.05g, D-ribose 0.05g;
(7) vitamin: vitamin A 0.2mg, vitamin E 3mg, vitamin C 30mg, vitamin D 0.1mg, Cobastab
10.5mg, Cobastab
20.5mg, Cobastab
60.5mg, Cobastab
120.1mg, nicotinic acid 0.5mg, folic acid 0.1mg, pantothenic acid 1mg, choline 50mg, niacinamide 0.5mg;
(8) mineral matter (the interpolation form of mineral matter is the organic or inorganic compound of this mineral matter): calcium 200mg, potassium 100mg, magnesium 100mg, iron 5mg, zinc 5mg, selenium 0.01mg, manganese 1mg, chromium 0.01mg, copper 0.1mg, molybdenum 0.01mg.
Above-mentioned raw materials is mixed, stir, through granulation, drying, whole grain is made graininess.After being used for 150ml temperature dissolved in boiled water, directly drinking or take in through nasal feeding.
Embodiment 3
The special meals product (powdery) in ocean of preparation patients with coronary heart disease special use
Present embodiment is selected powdery marine fish protein peptides, pearl powder, nacreous layer powder, chitosan, chitin oligo saccharide, ammonia sugar, laver powder, taurine, L-citrulling, L-aminobutanedioic acid, malto-oligosaccharide, galactolipin compound sugar, fructose oligosaccharides, lecithin, D-ribose, co-ferment and various vitamin and mineral matter, presses column weight amount proportioning and is prepared:
(1) marine oligopeptide: marine fish protein peptides 3.5g;
(2) marine bioactivity polysaccharide: pearl powder 0.4g, nacreous layer powder 0.4g, chitosan 0.4g, chitin oligo saccharide 0.4g, ammonia sugar 0.4g;
(3) seawood meal: laver powder 1.2g;
(4) nutrition amino acid: taurine 0.4g, L-citrulling 0.4g, L-aminobutanedioic acid 0.4g;
(5) compound sugar: malto-oligosaccharide 0.3g, galactolipin compound sugar 0.4g, fructose oligosaccharides 0.3g;
(6) nutrient: lecithin 0.2g, D-ribose 0.2g, co-ferment Q10 0.1g;
(7) vitamin: vitamin A 0.2mg, vitamin E 3mg, vitamin C 30mg, vitamin D 0.1mg, Cobastab
20.5mg, Cobastab
60.5mg, Cobastab
120.1mg, nicotinic acid 0.5mg, folic acid 0.1mg, pantothenic acid 1mg, choline 50mg, niacinamide 0.5mg;
(8) mineral matter (the interpolation form of mineral matter is the organic or inorganic compound of this mineral matter): calcium 200mg, potassium 100mg, magnesium 100mg, iron 5mg, zinc 5mg, selenium 0.01mg, manganese 1mg, copper 0.1mg, molybdenum 0.01mg.
Above-mentioned raw materials is mixed, stir,, make powdered food through super-dry.After about 150ml temperature dissolved in boiled water, directly drink or take in through nasal feeding.
Embodiment 4
The special meals product (graininess) in ocean of preparation patients with coronary heart disease special use
Present embodiment is selected seashells protein peptides, Sargassum protein peptide, marine fish collagen peptide, sea bone peptide, alginic acid zinc, shark chondroitin, seawater spirulina powder, chlorella powder, Dunaliella peircei powder, ulva lactuca powder, sea-tangle powder, skirt dish powder, laver powder, kelp powder, Algemin, pelvetia silquosa powder, Eucheuma powder, taurine, malto-oligosaccharide, galactolipin compound sugar, fructose oligosaccharides, oligoisomaltose, cow's milk compound sugar, xylo-oligosaccharide, D-ribose and the various vitamin and the mineral matter of powdery, is prepared by weight ratio:
(1) marine oligopeptide: seashells protein peptides 1.5g, Sargassum protein peptide 1.5g, marine fish collagen peptide 1.0g, sea bone peptide 1.0g;
(2) marine bioactivity polysaccharide: alginic acid zinc 0.5g, shark chondroitin 0.5g;
(3) seawood meal: seawater spirulina powder 0.2g, chlorella powder 0.2g, Dunaliella peircei powder 0.2g, ulva lactuca powder 0.2g, sea-tangle powder 0.2g, skirt dish powder 0.2g, laver powder 0.2g, kelp powder 0.1g, Algemin 0.1g, pelvetia silquosa powder 0.1g, Eucheuma powder 0.1g;
(4) nutrition amino acid: taurine 1.1g;
(5) compound sugar: malto-oligosaccharide 0.3g, galactolipin compound sugar 0.3g, fructose oligosaccharides 0.3g, oligoisomaltose 0.3g, cow's milk compound sugar 0.2g, xylo-oligosaccharide 0.1g;
(6) nutrient: D-ribose 0.1g;
(7) vitamin: vitamin A 0.2mg, vitamin E 3mg, vitamin C 30mg, vitamin D 0.1mg, Cobastab
10.5mg, Cobastab
20.5mg, Cobastab
60.5mg, Cobastab
120.1mg, nicotinic acid 0.5mg, folic acid 0.1mg, pantothenic acid 1mg, choline 50mg;
(8) mineral matter (the interpolation form of mineral matter is the organic or inorganic compound of this mineral matter): calcium 200mg, potassium 100mg, magnesium 100mg, iron 5mg, zinc 5mg, selenium 0.01mg, chromium 0.01mg, copper 0.1mg, molybdenum 0.01mg.
Above-mentioned raw materials is mixed, stir, through granulation, drying, whole grain is made graininess.After being used for 150ml temperature dissolved in boiled water, directly drinking or take in through nasal feeding.
Claims (10)
1. special meals product in the ocean of a patients with coronary heart disease special use, it is characterized in that with food source property marine oligopeptide be primary raw material, add marine bioactivity polysaccharide, be aided with seawood meal, nutrition amino acid, compound sugar, nutrient, vitamin and mineral matter again and be mixed with and form.
2. the special meals product in the ocean of patients with coronary heart disease special use according to claim 1 is characterized in that the weight portion proportioning of described marine oligopeptide, marine bioactivity polysaccharide, seawood meal, nutrition amino acid, compound sugar, nutrient, vitamin and mineral matter is:
Marine oligopeptide 3.5-5.0
Marine bioactivity polysaccharide 1.0-2.0
Seawood meal 1.2-1.8
Nutrition amino acid/11 .0-1.5
Compound sugar 1.0-1.5
Nutrient 0.1-0.5
Vitamin 0.01-0.1
Mineral matter 0.1-0.5.
3. the special meals product in the ocean of patients with coronary heart disease special use according to claim 1 and 2 is characterized in that described marine oligopeptide is a kind of, several or whole in marine fish protein peptides, seashells protein peptides, Sargassum protein peptide, marine fish collagen peptide and the sea bone peptide.
4. the special meals product in the ocean of patients with coronary heart disease special use according to claim 1 and 2, it is characterized in that described marine bioactivity polysaccharide is an algal polysaccharides, a kind of in ocean shell class polysaccharide and the marine animal polysaccharide, several or whole, wherein said algal polysaccharides is an agar, sodium alginate, carragheen, fucoidin, potassium alginate, calcium alginate, alginic acid zinc, a kind of in alginic acid iron and the alginic acid magnesium, several or whole, described ocean shell class polysaccharide is a pearl powder, nacreous layer powder, chitosan, a kind of in chitin oligo saccharide and the ammonia sugar, several or whole, described marine animal polysaccharide is one or both in glycosaminoglycan and the shark chondroitin.
5. the special meals product in the ocean of patients with coronary heart disease special use according to claim 1 and 2 is characterized in that described seawood meal is a kind of, several or whole in seawater spirulina powder, chlorella powder, Dunaliella peircei powder, ulva lactuca powder, sea-tangle powder, skirt dish powder, laver powder, kelp powder, Algemin, pelvetia silquosa powder and the Eucheuma powder.
6. the special meals product in the ocean of patients with coronary heart disease special use according to claim 1 and 2 is characterized in that described nutrition amino acid is a kind of, several or whole in L-arginine, taurine, L-citrulling and the L-aminobutanedioic acid.
7. the special meals product in the ocean of patients with coronary heart disease special use according to claim 1 and 2 is characterized in that described compound sugar is a kind of, several or whole in malto-oligosaccharide, galactolipin compound sugar, fructose oligosaccharides, oligoisomaltose, cow's milk compound sugar and the xylo-oligosaccharide.
8. the special meals product in the ocean of patients with coronary heart disease special use according to claim 1 and 2 is characterized in that described nutrient is a kind of, several or whole among lecithin, D-ribose and the co-ferment Q10.
9. the special meals product in the ocean of patients with coronary heart disease special use according to claim 1 and 2 is characterized in that described vitamin is vitamin A, vitamin D, vitamin E, vitamin C, Cobastab
1, Cobastab
2, Cobastab
6, Cobastab
12, a kind of, several or whole in nicotinic acid, folic acid, pantothenic acid, choline and the niacinamide.
10. the special meals product in the ocean of patients with coronary heart disease special use according to claim 1 and 2 is characterized in that described mineral matter is a kind of, several or whole in calcium, potassium, magnesium, iron, zinc, selenium, manganese, copper, chromium and the molybdenum.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102907759A CN102077940B (en) | 2010-09-20 | 2010-09-20 | Special dietary marine food for patients with coronary heart disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102907759A CN102077940B (en) | 2010-09-20 | 2010-09-20 | Special dietary marine food for patients with coronary heart disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102077940A true CN102077940A (en) | 2011-06-01 |
| CN102077940B CN102077940B (en) | 2013-04-24 |
Family
ID=44084291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010102907759A Expired - Fee Related CN102077940B (en) | 2010-09-20 | 2010-09-20 | Special dietary marine food for patients with coronary heart disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102077940B (en) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102308940A (en) * | 2011-08-08 | 2012-01-11 | 山东鲁健生物医药科技有限公司 | Composition containing oligopeptide and oligosaccharide for postoperative group to eat |
| US8283338B2 (en) | 2007-11-30 | 2012-10-09 | Kao Corporation | GIP secretion inhibitor |
| US8338389B2 (en) | 2009-06-17 | 2012-12-25 | Kao Corporation | Agent for preventing or ameliorating obesity |
| CN103461986A (en) * | 2013-07-18 | 2013-12-25 | 浙江劲膳美生物科技有限公司 | Special diet for patient with heart disease |
| CN103876033A (en) * | 2014-03-31 | 2014-06-25 | 邓林生 | Health coarse cereal mixed food and paste prepared from coarse cereal mixed food |
| CN103876034A (en) * | 2014-03-31 | 2014-06-25 | 邓林生 | Food containing polygonum multiflorum for treating coronary heart disease |
| CN104126791A (en) * | 2014-06-18 | 2014-11-05 | 胡安然 | Micro-ecological special dietary for atherosclerotic patients to eat |
| CN104223112A (en) * | 2014-08-25 | 2014-12-24 | 胡安然 | Micro-ecological special diet for patients suffering from arrhythmia |
| CN106213490A (en) * | 2016-07-22 | 2016-12-14 | 柳州名品科技有限公司 | It is applicable to the health food of cardiac |
| CN107773754A (en) * | 2016-08-24 | 2018-03-09 | 华仁药业股份有限公司 | A kind of enteral nutritional composition for patients with mechanical ventilation and preparation method thereof |
| CN109567208A (en) * | 2019-01-04 | 2019-04-05 | 广东海洋大学 | Enteral nutrition preparation and its preparation method and application containing marine bioactivity polysaccharide |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110301647A (en) * | 2018-11-29 | 2019-10-08 | 陈�峰 | The compound oligomeric peptide nutrient food of ground dragon protein |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101015352A (en) * | 2007-01-12 | 2007-08-15 | 广州蓝钥匙海洋生物工程有限公司 | Ocean functional food with weight-reducing and blood lipoid reducing functions |
-
2010
- 2010-09-20 CN CN2010102907759A patent/CN102077940B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101015352A (en) * | 2007-01-12 | 2007-08-15 | 广州蓝钥匙海洋生物工程有限公司 | Ocean functional food with weight-reducing and blood lipoid reducing functions |
Non-Patent Citations (1)
| Title |
|---|
| 《营养与食品--健康中国高级论坛Ⅱ论文集》 20080501 潘兴昌等 食源性低聚肽与特殊膳食食品的开发 第131-137页 1-10 , * |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8283338B2 (en) | 2007-11-30 | 2012-10-09 | Kao Corporation | GIP secretion inhibitor |
| US8338389B2 (en) | 2009-06-17 | 2012-12-25 | Kao Corporation | Agent for preventing or ameliorating obesity |
| CN102308940A (en) * | 2011-08-08 | 2012-01-11 | 山东鲁健生物医药科技有限公司 | Composition containing oligopeptide and oligosaccharide for postoperative group to eat |
| CN103461986A (en) * | 2013-07-18 | 2013-12-25 | 浙江劲膳美生物科技有限公司 | Special diet for patient with heart disease |
| CN103876034B (en) * | 2014-03-31 | 2016-03-23 | 九江天兴农业发展有限公司 | Containing the food of Semen sesami nigrum |
| CN103876033A (en) * | 2014-03-31 | 2014-06-25 | 邓林生 | Health coarse cereal mixed food and paste prepared from coarse cereal mixed food |
| CN103876034A (en) * | 2014-03-31 | 2014-06-25 | 邓林生 | Food containing polygonum multiflorum for treating coronary heart disease |
| CN104126791A (en) * | 2014-06-18 | 2014-11-05 | 胡安然 | Micro-ecological special dietary for atherosclerotic patients to eat |
| CN104223112A (en) * | 2014-08-25 | 2014-12-24 | 胡安然 | Micro-ecological special diet for patients suffering from arrhythmia |
| CN106213490A (en) * | 2016-07-22 | 2016-12-14 | 柳州名品科技有限公司 | It is applicable to the health food of cardiac |
| CN107773754A (en) * | 2016-08-24 | 2018-03-09 | 华仁药业股份有限公司 | A kind of enteral nutritional composition for patients with mechanical ventilation and preparation method thereof |
| CN107773754B (en) * | 2016-08-24 | 2020-10-16 | 华仁药业股份有限公司 | Enteral nutrition composition for mechanically ventilated patients and preparation method thereof |
| CN109567208A (en) * | 2019-01-04 | 2019-04-05 | 广东海洋大学 | Enteral nutrition preparation and its preparation method and application containing marine bioactivity polysaccharide |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102077940B (en) | 2013-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102077936B (en) | Special sea dietary food for diabetics | |
| CN102077940B (en) | Special dietary marine food for patients with coronary heart disease | |
| CN102077934B (en) | Special dietary marine food for patients with high blood pressure | |
| CN102077939B (en) | Marine special dietary food special for fat people | |
| CN102077945B (en) | Special dietary seafood for postabortal and postpartum women | |
| CN102077933B (en) | Special dietary seafood special for hyperuricemia patients | |
| CN102077938B (en) | Special marine dietary food for patients with liver deficiency | |
| CN102077937B (en) | Special dietary seafood special for young and middle-aged women | |
| CN102077942B (en) | Marine special dietary food special for patient with bone disease | |
| CN102077944B (en) | Marine special dietary food special for prostate patient | |
| CN107455698A (en) | A kind of ocean polypeptide spy's dietary seafood for being used to promote intelligence development | |
| CN107495387A (en) | A kind of ocean polypeptide spy's dietary seafood as sports tonica | |
| CN104855994A (en) | Non-full nutritional formula food for patients with nephropathy | |
| CN104855997A (en) | Non-whole nutrient formula food for osteoporosis | |
| CN1315418C (en) | Instant drinking powder contg. black-fungus, oatmeal and spirulina, and its prepn. method | |
| CN107616507A (en) | A kind of ocean polypeptide spy's dietary seafood for chornic arthritis edible for patients | |
| CN102077943B (en) | Seafood for special dietary uses for hypomnesia patients | |
| CN104431170A (en) | Marine bioactive polysaccharide or oligosaccharide granular tea drink for improving metabolic syndrome (six highs and one lipid) | |
| CN102077935B (en) | Marine special dietary food special for vision recession patient | |
| CN105410930A (en) | Health-care product with weight-losing and body-slimming and nutrition-balancing functions and preparation method thereof | |
| CN102018158A (en) | Aloe jam | |
| CN102077941B (en) | Special dietary seafood special for climacteric women | |
| CN107549692A (en) | A kind of ocean polypeptide spy's dietary seafood for patients undergoing chemotherapy post-operative recovery | |
| CN104839709A (en) | Gastrointestinal absorption barrier non-total nutrient formula food | |
| CN104921100A (en) | Non-total nutrient formula food for recuperating from chloasma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20151230 Address after: 510300, room 11, 1710 art street, Xingang Middle Road, Guangzhou, Guangdong, Haizhuqu District Patentee after: Guangzhou Blue Key Ocean Bioengineering Co., Ltd. Address before: 1710, room 11, block A, arts street, No. 510300, Xingang Road, Guangzhou, Guangdong Patentee before: Wang Qiang |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130424 Termination date: 20190920 |